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LEUKOCYTE AND LYMPHOCYTE CYCLIC AMP RESPONSES IN ATOPIC 
ECZEMA 
CHARLES W. PARKER, M.D., SUSAN KENNEDY, M.D., AND ARTHUR z. EISEN, M.D. 
Department of Medicine , Divisions of Immunology and Dermatology, Washington, U niuersity School of Medicine, 
St. Louis, Missouri , U.S. A . 
Lymphocytes from subjects with mild and severe atopic eczema were compared with 
normal control subjects in regard to their cAMP (3';5'-cyclic adenosine monophosphate) 
responses to a variety of stimulatory agents. Individuals in the severe eczema group were 
shown to have a significant diminution in their unstimulated lymphocyte cAMP levels and 
absolute cAMP responses to 0.5 mM theophylline, 0.5 mM theophylline+ 1 JJ.M epinephrine, 
10 mM isoproterenol, 1 mM isoproterenol, 10 mM salbutamol, and 3 1-tM PGE,. Individuals 
with mild eczema had a reduced response to 0.5 mM theophylline. The severe eczema groups 
also differed in a number of these responses from a group of5 subjects with severe psoriasis. 
Mixed leukocyte cAMP responses to 10 mM isoproterenol also were examined and found to be 
diminished in individuals with eczema. 
A systemic alteration in beta-adrenergic respon-
siveness is observed frequently in individuals with 
severe and persistent allergic bronchial asthma 
(reviewed in [l-3]), but the mechanism is uncer-
tain and in some individuals concurrent broncho-
dilator therapy may be a contributory factor [1,4-
7]. Unfortunately, it often is not possible to with-
hold medications from asthmatic subjects for a 
sufficiently long period of time to exclude residual 
effects of therapy. In attempting to determine 
whether the altered catecholamine response is a 
reflection of the allergic state, per se, an alterna-
tive approach is to study individuals with atopic 
eczema who have not received bronchodilator ther-
apy. This condition frequently is associated with 
bronchial hyperreactivity to cholinergic agents, 
high serum IgE levels, and, in some, the eventual 
development of overt asthma LB-11]. We have pre-
viously presented preliminary evidence that circu-
lating leukocytes from individuals with atopic ec-
zema have a statistically reduced cAMP (3';5'-
cyclic adenosine monophosphate) response to cate-
cholamines in vitro [10]. The present report de-
scribes the results of more detailed studies in this 
condition including serial observations in a num-
ber of affected individuals. 
MATERlALS AND METHODS 
Methods for studying hormonal responsiveness in 
isolated human leukocytes and lymphocytes in vitro 
have been described in detail previously [4,12]. Mixed 
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leukocytes were obta.ined from heparinized peripheral 
blood by dextran sedimentation followed by 2 room-
temperature washes in phosphate-saline (0.15 M NaCl, 
0.01 M phosphate, pH 7 .4) and 2 low-speed centrifuga-
tions to remove platelets. The quantity of blood used 
varied from 25 to 150 mL Preparations usually con-
tained 25-40% lymphocytes , the majority of the remai n-
ing cells being polymorphonuclear leukocytes. Purified 
lymphocytes were obtained from dextran-sedimented 
mixed leukocytes by Ficoll-Hypaque (Pharmacia Fine 
Chemicals, Piscataway, N.J .l density gradient centrif-
ugation yielding 92-99% lymphocytes and few, if any, 
erythrocytes. The remaining cells were granulocytes 
and monocytes. The average lymphocyt e recovery was 
70%. All purified cell preparations were centrifuged at 
low speed to remove platelets. 
Reagents and solutions. Reagents and their sources 
were described previously [4]. Solutions of catechol-
amines (DL-isoproterenol · HCl, ! -norepinephrine · 
HCI, and ! -epinephrine · H ClJ and theophylline were 
prepared in 0.15 M NaCl just before use. 
Cyclic AMP determtnations. Mixed leukocytes were 
suspended in Gey's solution, pH 7.8 [13], or Krebs-
Ringer bicarbonate buffer (Krebs' buffer ), pH 7.5 [14], 
at a concentration of 4-8 x 10u mixed leukocytes/mJ. 
Purified lymphocytes were used at a concentrat ion of2-
5 x 1011 cells/mL Volumes of0.5 mJ of the cell suspension 
were added to each tube. Additions were made at room 
temperature. Catecholamines, buffer, and other solu-
tions were added in a volume of 0.05 ml and the cells 
were incubated for 1-60 min at 37•c . The pH of the cell 
suspensions was stable except at the highest isoprotere-
nol and norepinephrine concentrations (10 mM) where 
there was a fall of about 0.3 pH unit over a 30-min 
period (Gey's solution only). In experiments with pH 
adjusted, 10 mM isoproterenol and norepinephrine solu-
tions gave slightly lower cAMP values. After incuba-
tion the cells were centrifuged at 2500 rpm for 2 min at 
room temperature. The supernatant solutions were de-
canted and the pellets frozen in ethanol-dry ice. Speci-
mens were stored at or below - 7o•c until assay. 
Cyclic AMP was determined by radioimmunoassay 
using antibody to 2' -0-succinyl-cyclic AMP and f'25l]2'-
0-succinyl-cyclic AMP-tyrosine methyl ester. Details in 
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regard to the sensitivity and specificity of the cAMP 
immunoassay have been presented previously l15]. 
Immunofluorescent staining. Ficoll-Hypaque puri-
fied cells were stained for surface immunoglobulins by 
a fluorescence double-antibody technique using a mix-
ture of rabbit antibodies specific for human lgG and 
[gM as the first antibody and fluoresceinated goat an-
tirabbit IgG as the second antibody l4]. Individual rab-
bit antisera were shown to be monospecific by immuno-
electrophoresis, and positive fluorescent staining re-
sponses were blocked almost completely by the appro-
priate human Ig at a concentration of 1 mg/ml. Percent-
ages of stained cells were corrected for the number of 
monocytes in the preparation. With Ficoll-Hypaque 
purified lymphocytes the mean corrected percentage of 
fluorescent cells in 12 normal control subjects was 19.5 
(::!: 1.1, SEM). 
Human subjects. Human adult or teen-age volun-
teers were obtained from the patient population and 
employees of Barnes Hospital and Washington Univer-
sity School of Medicine. Almost a1l of the individuals in 
the atopic eczema group were private or clinic patients 
(of A.Z.E.), some of whom have been followed for pe-
riods in excess of 5 years. Data are available on a total 
of 48 subjects with atopic eczema (including individuals 
both with severe-characterized by pruritus, erythema, 
and lichenification involving at least 15% or greater of 
their body surface-and mild or inactive disease) but 7 
of these were eliminated because of concurrent therapy 
or incomplete historical information. Subjects receiving 
systemic corticosteroids, oral contraceptives, or an-
tiasthmatic medications were excluded from the study. 
None of the individuals diagnosed as having atopic 
eczema had had persistent symptoms of bronchial 
asthma. Controls included 40 previously reported sub-
jects covering the age, race, and sex range of the patient 
population as well as an additional 20 subjects studied 
in parallel with the eczema patients. In addition, 5 
subjects with clinically active psoriasis were studied. In 
the normal control group no consistent differences in 
responsiveness with respect to age, race , or sex were 
noted. Statistical analysis was by Student's t-test. 
RESULTS 
In leukocytes incubated in Gey's solution for 30 
min at 37"C, cells from individuals with atopic 
eczema (12 subjects, the majority with extensive 
disease) exhibited a significantly reduced cAMP 
response to 10 mM isoproterenol, a concentration 
shown previously to give a maximal response. In 
cells from patients with eczema, cAMP values rose 
only 10 picomoles per 10; cells as compared with 26 
picomoles in control cells (p < 0.05) (Tab. I). The 
TABLE I. Leukocyte cAMP responses in individuals with 
eczema 
Mixed peripheral blood leukocytes were incubated in 
Gey's solution for 30 min at 37"C as described in Materi-
als and Methods; given as the mean ( :!: SEMJ. 
Num-
Picomoles per 10' cells 
ber Unstimulated 10 mM lsoprotere-no! 
Eczema 12 7.16 (:!: 0.78) 17.2 (± 3.54)" 
Control 40 8.10 (± 0.50) 34.6 (± 5.0) 
• Statistically different from control cells (p < 0.05). 
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FIG. 1. Isoproterenol stimulation of mixed leukocytes 
as a function of time. Cells suspended in Krebs' buffer 
were stimulated with 10 mM isoproterenol for the indi-
cated time periods in the absence and presence of 0.5 
mM theophylline. The results are the mean (± SEM) of 
4 experiments with normal control cells and 4 experi-
ments with cells from individuals with atopic eczema. 
Cyclic AMP values in unstimulated cells remained 
within 10% of the initial value over the 30-min time 
period. 
buffer used did not affect the results, since when 
cells from an additional10 subjects were incubated 
for either 15 or 30 min at 37°C in Krebs' lactate 
buffer, rather than Gey's solution, similar results 
were obtained (not shown). Studies of the time 
course of isoproterenol stimulation revealed that 
differences in 4 subjects (selected by previous 
screening as showing decreased cAMP responsive-
ness) when compared to 4 controls were demon-
strable at 2 min and 5 min as well as at later 
times, indicating that prolonged incubation times 
are not needed to see differences between the two 
groups (Fig. 1). In the same experiment differ-
ences in cAMP responsiveness also were seen at 
lower concentrations of isoproterenol (Fig. 2). 
The next question we considered was the role of 
cellular heterogeneity in the altered cAMP re-
sponse. During studies of adrenergic responses in 
asthmatic subjects, lymphocytes were found to ac-
count for most of the cAMP response to hormonal 
agents. making purified lymphocytes the most 
suitable cells for study [ 4]. When purified lympho-
cytes from individuals with extensive eczema and 
normal subjects were compared, again significant 
differences in the cAMP response to 10 mM isopro-
terenol were seen by comparison either with con-
currently studied control subjects (Tab. ll) (p < 
0.005) or with a considerably larger group of con-
trol subjects studied under identical conditions 
over a period of several years (p < 0.005) (not 
shown). Thus, variations in the number ofneutro-
phils, eosinophils, or monocytes are not the basis 
for the differences in leukocyte responsiveness. 
While alterations in relative proportions ofT- and 
B-lymphocytes in eczema still had to be considered 
[16,17], immunofluorescence studies in lympho-
cytes from 3 individuals whose isoproterenol re-
sponse was considerably reduced revealed only 
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small changes in T-cell-B-cell distribution (26 [± 
3, SEM] % B-cells as compared with 19.5 l± 1.1, 
SEM] % in 10 normal controls). 
Differences of this magnitude would not be ex-
pected to alter significantly hormonal responsive-
ness. Moreover, previous studies suggest that, if 
anything, catecholamine responsiveness is greater 
in B-cells than in T-cells [4]. Nonetheless, it 
should be kept in mind that we cannot completely 
exclude a more marked alteration in a subpopula-
tion of T-cells. 
5 
-o + Ql 
0 
:::> 4 
E 
- "' 
.,_ 
0 Ql 3 u 
0 -
::. 2 
2 0 c 
~ 
r+ 
a..- 0 
~ u 
<( 0 
~ 
u 
>-
~ 
" I 
u 10,000 1,000 100 10 
Isoproterenol Conc entro t1on, J.IM 
FIG. 2. The cAMP response of mixed lelilocytes to a 
range of concentrations of isoproterenol. Cells were 
incubated in Krebs' buffer for 30 min at 37"C. The 
results given are the experimental means from 4 exper-
iments each with leukocytes from individuals with se-
vere atopic eczema (closed bars) and normal controls 
(open bars). They are expressed as the percent increase 
above 30-min buffer control values (6.4 and 5.9 pico-
moles/107 cells, respectively) z SEM. No theophylline 
was present. 
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Other pharmacologic stimuli and lower concen-
trations of isoproterenol were examined with puri-
fied lymphocytes. Individuals with severe eczema 
also showed a reduced response to a 10-fold lower 
concentration of isoproterenol. Responses to pros-
taglandin E 1 (PGE~> 3 J.LM), theophylline (0.5 mM), 
salbutamol (10 mM), a selective B2 agonist, and 
epinephrine (1 J.LM) + theophylline (0.5 mM) were 
all decreased as were unstimulated cell cAMP val-
ues, although not at the same level of statistical 
significance as the 10 mM isoproterenol response 
(Tab. II). The mean 1 J.LM epinephrine response 
also was less marked (25 vs 47 picomoles/107 cells, 
respectively) but not to a level of statistical signifi-
cance (0.05 < p < 0.10). It is therefore apparent 
that the alteration in cAMP metabolism is not 
limited strictly to adrenergic stimuli . 
In contrast to the results in extensive eczema, 
less severe disease was not associated with statis-
tically significant alterations in lymphocyte re-
sponsiveness although with most of the stimuli 
some reduction in the mean cAMP response was 
seen, suggesting that at least some individuals in 
this group are intermediate in their response 
(Tab. Ill. The single exception was the 0.5 mM 
theophylline r esponse which was significantly re-
duced relative to control subjects. 
Serial studies conducted in leukocytes or lym-
phocytes on at least 3 occasions over a 4-year pe-
riod are available in 3 originally severely affected 
individuals. In 1 of the 3 subjects, hormonal re-
sponsiveness was markedly decr eased on each of 
the 6 occasions on which the analysis was made. In 
the other 2 subjects, lymphocyte responsiveness 
increased in association with marked clinical im-
provement. In 2 other subjects studied on at least 2 
occasions the severity of the defect appeared to 
correlate with disease activity. 
TARLE ll. Comparison of lymphocyte cAMP responses in severe and mild eczema, psoriasis, and normal controls 
Purified lymphocytes were incubated in Gey's solution for 30 min at 37°C. Data are given as the mean (± SEMl. 
Normal Severe eczema• Mild eczema Psoriasis 
Number of subjects 12" 9 16 5 
Buffer 25.3 ± 4.1 15.3 ± 3.3 17.4:!: 2.8 36.8 ± 12.0 
Theophylline 0.5 mM 44.2 ± 12.8 15.8 ± 3.7 19.2 ± 3.9 51.7 ± 18.7 
Epinephrine 1 IJ.M 47.0 ± 10.2 25.2 ± 6.6 30.0 ± 7.4 103.0 ± 32.0 
Epinephrine 1 J.LM + theo- 62.0 ± 11 .2 30.7 ± 8.7 47.0 ± 9.1 117.0 ± 36.0 
phylline 0.5 mM 
Isoproterenol 10 mM 164.0 ± 18.9 61.0 ± 9.8 168.0 ± 19.0 71.0 ± 15.8 
Isoproterenol 1 mM 99.7 ± 21.8 25.9 ± 3.3 65.0 :!: 16.0 
Salbutamol 10 mM 57.2 ± 13.9 18.4 ± 7.5 68.0 ± 18.7 
PGE, 3 ~J.M 150.3 :t: 38.0 61.8 ± 20.0 119.0 ± 30.2 264.0 ± 79.0 
• Cyclic AMP values (picomoles/107 lymphocytes) in 40 additional control subjects studied under identical 
conditions but not concurrently with eczema patients were: buffer control 26 (± 3), 3 J.LM PGE, 148 ( ± 20), 10 mM 
isoproterenol 140 (z 15). Similar statistical results are obtained comparing these values with those in subjects with 
atopic eczema. 
b The cells from patients with severe eczema were statistically different from normal control cells in buffer (p < 
0.05), 0.5 mM t heophylline (p < 0.05), 0.5 mM theophylline + 1 IJ.M epinephrine (p < 0.025), 10 mM isoproterenol (p 
< 0.0005), 1 mM isoproterenol (p < 0.025), 10 mM salbutamol (p < 0.05), and 3 J.LM PGE1 (p < 0.05). The severe 
eczema group was statist ically different from the severe psoriasis group in buffer (p < 0.025), 0.5 mM theophylline 
(p < 0.025), 11J.M epinephrine (p < 0.005), 0.5 IDM theophylline + 1 IJ.M epinephrine (p < 0.01), and 3 IJ.M PGE, (p < 
0.005). The mild eczema group was statistically different from the control group in their response to theophylline (p 
< 0.05). 
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To determine whether the alteration in lympho-
cyte responsiveness was specifically associated 
with atopic eczema or would be manifest in sub-
jects with another skin disease in which altera-
tions of cAMP have been implicated [18], 5 sub-
jects with generalized, long-standing psoriasis also 
were studied. While apparent alterations in phar-
macologic responsiveness were seen, the pattern 
was quite different from that of the severe eczema 
group. Somewhat paradoxically, the response to 
epinephrine 1 IJ.M and epinephrine 1 IJ.M + theo-
phylline was actually increased, whereas the re-
sponse to isoproterenol (10 mM) was dimirushed. 
Unfortunately, lower concentrations of isoprotere-
nol were not examined. It is possible that if this 
had been done, increased responsiveness would 
have been seen to isoproterenol as well as to epi-
nephrine (as might be true if the 10 mM isoprotere-
nol response was at the upper end of a bell-shaped 
dose-response curve). 
DISCUSSION 
The results of the present study confirm our 
earlier observations on the reduction of catechol-
amine responsiveness in leukocytes from individ-
uals with severe atopic eczema flO] and show, in 
addition, that responses in their purified lympho-
cytes also are altered. The alterations in leukocyte 
cAMP metabolism seen are generally similar to 
those in severe bronchial asthma where unstimu-
lated cAMP levels and responses to isoproterenol. 
epinephrine, and epinephrine or isoproterenol and 
theophylline are all reduced [19]. While PGE, re-
sponsiveness is usually well maintained in asth-
matic individuals, the most severely affected sub-
jects sometimes exhibit reduced responsiveness to 
PGE, . In individuals with severe eczema, a statis-
tically significant decrease in PGE, responsive-
ness is seen, but the response to isoproterenol is 
more markedly affected. Since there is some re-
duction in resting cAMP levels and PGE, and 
theophylline responsiveness, it is apparent the de-
fect is not entirely limited to the beta-adrenergic 
system per se. Among the possibilities are de-
creased substrate (ATP) concentrations or availa-
bility to the adenylate cyclase, loss of a cofactor in 
the adenylate cyclase response such as GTP, or 
ineffective coupling between hormonal receptors 
and the cyclase. However, the decreased response 
to theophylline argues agajnst the third possibil-
ity. An increase in phosphodiesterase activity also 
must be considered although if this is the mecha-
njsm the enzyme appears to be relatively resistant 
to theophylline. It also appears that the magni-
tude of the alteration is related to the clirucal 
activity of the inflammatory process in the skin. 
Thus, the changes appear to be, at least in part, 
acquired rather than congenital, in some way re-
flecting the severity of the underlying disea~ 
process in the skin. Similar conclusions have been 
drawn in bronchial asthma where individuals 
with long periods of clinical inactivity have nor-
mal or near normal responses l4]. In less extensive 
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studies in individuals with psoriasis, alterations 
in leukocyte responsiveness also occur to a more 
limited extent, but the pattern is different from 
that seen in severe eczema, and it seems necessary 
to assume that different mechanisms are involved. 
Our findings in psoriasis of an increased lympho-
cyte cAMP response to epinephrine resemble those 
in skin by Voorhees and Duell [18) who found that 
the response to 1 p.M isoproterenol was normal or 
increased. Our fmdjngs of reduced catecholamjne 
responses in severe atopic eczema, on the other 
hand, are similar to those of Halprin et al l20] in 
psoriatic skin. Since extensive skin disease per se 
does not appear to explain the alteration, the oc-
currence of altered leukocyte responsiveness in 
association with severe atopic eczema strengthens 
the argument that the changes seen in asthmatic 
subjects are not due solely to antiasthmatic ther-
apy. 
Since cAMP was measured in isolated lympho-
cytes rather than whole blood it is possible that 
the changes in hormonal responsiveness that are 
seen are in part a reflection of the isolation proce-
dure. Nonetheless, previous studies indicate that 
altered responses are observable even after iso-
lated lymphocytes have been majntained in tissue 
culture for several hours. Moreover, since the cells 
are handled identically, some preexisting altera-
tion in cellular metabolism must be involved. The 
10 mM isoproterenol concentration was selected 
because it produces maximal increases in cAMP in 
human lymphocytes. While this concentration is 
very high relative to the concentrations of isopro-
terenol achieved in vivo, the responses are largely 
inhibited by beta-adrenergic blocking agents, indi-
cating that beta-adrenergic receptors are involved. 
Moreover, similar changes are seen with epineph-
rine concentrations which produce easily measur-
able responses at concentrations in the low p.M 
range. 
The basis for the defect in subjects with atopic 
eczema will require further study. A variety of 
observations over a period of several decades sug-
gests that cutaneous vascular activity is altered in 
this disease. Carr et al [21] studied proliferative 
responses in vitro of skin biopsy specimens from 
individuals with atopic eczema. Inhibition of cell 
replication by catecholamines was seen in normal 
skin in accord with earlier observations [18] but 
not in eczematous skin, suggesting that atopic 
eczema was associated with a defect in cutaneous 
catecholamine responsiveness similar to that seen 
in lymphocytes. Later, direct measurements of the 
cAMP response in skin suggested that marimal 
absolute isoproterenol responses were normal, 
whereas unstimulated cAMP levels were in-
creased 2-fold [22]. Measurements of cutaneous 
adenylate cyclase, cAMP-dependent protein ki-
nase, and cAMP phosphodiesterase also have been 
reported both in this condition and in psoriasis 
[18,23-25]. Further work is needed both in skin 
biopsy material and leukocytes to define more pre-
cisely the nature of the changes and elucidate 
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their mechanism. One possibility is that the al-
tered responsiveness is secondary to release of one 
or several inflammatory mediators of immediate 
hypersensitivity such as prostaglandins, chemo-
tactic factors, SRS-A, or histamine. 
We wish to thank Ms. Mary Huber and Ms. Mary 
Baumann for excellent technical assistance. 
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